Single Use Ophthalmic Surgical Devices Market Size, Share & Trends Analysis Report, By Product (Forceps, Speculum, Nucleus Rotators & Choppers), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report Overview

The global single use ophthalmic surgical devices market size was valued at USD 7.38 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. This market growth can be attributed to the increasing prevalence of ophthalmic disorders such as myopia, cataracts, diabetic retinopathy, and more, which require surgical procedures. Patients have increasingly preferred single use ophthalmic devices due to their ability to reduce the risk of cross-contamination and hospital-acquired infections which are a significant concern with reusable instruments. These devices offer high safety and precision for the treatment of ophthalmic disorders and require low maintenance with zero need for cleaning and sterilization.

Technological advancements in the design and manufacturing of single use ophthalmic surgical devices have played a crucial role in market growth. Innovations such as more precise and ergonomically designed instruments enhance the safety and efficacy of surgical procedures. These devices provide sharpness and precision enabling surgeons to perform accurate surgical operations. In addition, the development of new materials that improve the performance and reduce the cost of these devices has made them more accessible to a broader range of healthcare facilities. The growing acceptance of these devices has encouraged key market players to introduce ophthalmic devices with better precision and different shapes and sizes.

Single use devices are particularly advantageous in high-volume ophthalmic surgical settings, where quick turnaround time and reduced risk of infection are critical. This trend is supported by the growing awareness of eye health and the importance of timely surgical interventions, driven by initiatives from both governmental and non-governmental organizations

Moreover, growing awareness regarding ophthalmic procedures and increased investment by government and private medical institutes to offer better surgical treatment have fueled the market growth. Favorable reimbursement policies made by medical institutes help offset the high initial costs of single use devices compared to reusable ones, which makes them a viable option for healthcare providers.

Product Insights

The forceps segment dominated the market with a share of 18.8% in 2023 attributed to the rising prevalence of conditions such as glaucoma, cataracts, myopia, and more. Forceps are essential tools in delicate eye procedures including cataract extraction and retinal detachment repair. In addition, the easy accessibility and affordability of forceps are some of the major market drivers. Major companies have targeted to launch forceps with better precision by improving the material quality and ergonomics of the device.

Ophthalmic Viscoelastic Devices (OVDs) are expected to emerge as the fastest-growing segment with a CAGR of 10.2% over the forecast period owing to the rising prevalence of cataracts and other ophthalmic disorders among the geriatric population. These devices are used to protect ocular tissues including corneal endothelium, maintain anterior chamber stability and depth, and facilitate surgical maneuvers during eye surgeries. Moreover, the development of OVDs with improved viscoelastic properties, such as enhanced cohesiveness and dispersiveness, has led to better surgical outcomes and increased surgeon preference. Additionally, the availability of OVDs in prefilled syringes has simplified their use, reduced preparation time, and minimized the risk of contamination.

Application Insights

Cataract surgeries have accounted for the dominant share in 2023 owing to the increasing incidence of cataracts, particularly among the aging population. Cataract surgery is one of the most common and effective procedures to restore vision, which makes it a critical application in the ophthalmic surgical devices market. The continuous market demand has encouraged key players to introduce innovative products such as femtosecond lasers and advanced intraocular lenses (IOLs) that improve the safety and efficacy of surgical procedures.

Diabetic retinopathy is projected to grow at a CAGR of 8.3% over the forecast period. The increasing prevalence of diabetes worldwide owing to lifestyle-related factors such as obesity and sedentary habits, directly correlates with a rise in diabetic retinopathy cases. This surge in diabetic retinopathy cases necessitates more frequent and advanced surgical interventions. Innovations such as optical coherence tomography (OCT) and advanced laser treatments have improved the precision and outcomes of diabetic retinopathy surgeries. These technologies, often integrated into single use devices, enhance the safety and efficacy of procedures. In addition, the development of minimally invasive surgical techniques has further driven the adoption of single use devices, as they reduce recovery times and improve patient outcomes.

End Use Insights

Hospitals accounted for the dominant market share of 30.7% in 2023. Patients have increasingly depended on hospitals for complex eye surgeries such as cataract removals, glaucoma treatment, and retinal repairs as they are equipped with advanced surgical facilities and specialized ophthalmic units. The high procedural volume in hospitals necessitates the use of single use devices to ensure patient safety and reduce the risk of cross-contamination and hospital-acquired infections. These devices are pre-sterilized, ready-to-use instruments that enhance surgical efficiency and reduce preparation time. Such characteristics make them highly suitable for high-volume surgical environments including hospitals.

Ambulatory surgical centers are expected to register at a CAGR of 8.5% segment over the forecast period owing to the increasing preference for outpatient surgical procedures due to their cost-effectiveness and convenience. Moreover, ASCs offer more affordable alternatives to hospital-based surgeries, with lower overhead costs and shorter patient stays. This economic advantage has particularly appealed to regions with high healthcare costs, driving the adoption of single use ophthalmic surgical devices in these settings. These centers offer specialized patient care aiding in efficient treatment and faster recovery.

Regional Insights

The North America single use ophthalmic surgical devices market held 33.9% of the global revenue share in 2023 owing to the rising number of patients with conditions including cataracts, myopia, retinopathy, glaucoma, and more. Furthermore, the increased awareness regarding ophthalmic procedures coupled with rising disposable income has resulted in patients opting for ophthalmic surgeries to treat their eye disorders.

U.S. Single Use Ophthalmic Surgical Devices Market Trends

The single use ophthalmic surgical devices market in the U.S. was propelled by the well-established healthcare infrastructure that catered to the rising prevalence of ophthalmic disorders. Additionally, major lifestyle shifts have resulted in increased exposure to blue light owing to excessive use of TVs, mobile phones, and computers. This has significantly increased the number of patients with eye disorders.

Europe Single Use Ophthalmic Surgical Devices Market Trends

The Europe single use ophthalmic surgical devices market held a lucrative market share in 2023 credited to the presence of major healthcare institutes and the growing acceptance of single use ophthalmic surgical devices in the region. The rising geriatric population diagnosed with eye disorders such as cataracts, myopia, and more has resulted in an increased demand for efficient ophthalmic devices. Furthermore, favorable reimbursement policies have resulted in patients seeking ophthalmic surgeries to treat their eye disorders.

Asia Pacific Single Use Ophthalmic Surgical Devices Market Trends

The single use ophthalmic surgical devices market in Asia Pacific is expected to witness the fastest CAGR of 9.0% attributed to the population growth in developing economies such as China, India, and Japan, and the robust development in the healthcare industry. In addition, regional governments and private medical institutes have largely invested in technological advancements to improve the efficiency of single use ophthalmic devices.

Key Company Share & Insights

The competitive landscape of the market has significantly shaped the market growth. Major players in the industry such as Stephen Instruments, Surgitrac Instruments UK Limited, Sterimedix Limited, and others have continuously invested in research and development to introduce innovative products that meet the evolving needs of surgeons and patients. This competition drives technological advancements and helps lower the costs of single use devices, making them more affordable and accessible.

• Surgitrac Instruments UK Limited is a medical device company specializing in the production and sale of ophthalmic surgical instruments. The company deals with equipment such as ophthalmic instruments, corneal grafts, operating tables/ stools/ chairs, ophthalmic packs and sets, and more.

• BVI is a medical device company that specializes in the development and manufacturing of ophthalmic medical equipment for disorders including cataracts, glaucoma, vitreoretinal, and more. The company also provides consumables for procedures of cornea, dry eyes, lacrimal, oculoplasty, and other refractive procedures.

Recent Developments

• In September 2023, BVI announced its acquisition of Medical Mix, which offers ophthalmic surgical devices in Portugal and Spain. This acquisition has enhanced BVI’s presence in the European markets.

• In June 2023, BVI introduced FINEVISION HP in Japan. This glistening-free and hydrophobic trifocal IOL is the first of its kind, providing cataract patients with high-quality vision at all distances.

Single Use Ophthalmic Surgical Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global single use ophthalmic surgical devices market report based on product, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Forceps

  • Speculum

  • Nucleus Rotators & Choppers

  • Curettes

  • Cannulas

  • Knives

  • OVD

  • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diabetic Retinopathy

  • Cataract Surgery

  • Glaucoma Surgery

  • Refractive Surgery

  • Corneal Surgery

  • Vitreo-Retinal Surgery

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ophthalmic Clinics

  • ASCs

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait